Literature DB >> 28630380

The Immunological Basis in the Pathogenesis of Gout.

Junwei Chen1, Meng Wu, Jinhua Yang, Jing Wang, Yue Qiao, Xiaofeng Li.   

Abstract

Gout is an inflammatory arthritis characterized by red, tender, hot and tumid joints. The development cause and process of gout is very sophisticated; recent studies, notwithstanding, have offered novel perspectives on the mechanism from an immunological viewpoint. The pathological process of gout involves both innate and adaptive immune responses. Other studies have demonstrated that gout development is associated with the presence of monosodium urate (MSU) crystals which serve as a "danger signal" affecting certain immune cells, cytokine production, and effector molecule expression, triggering both types of immune responses. Different cell subsets, cytokines, pattern recognition receptors (PRRs) and the inflammasome have had noticeable effects on the pathogenesis of gout. In the present review, we discuss the contributions of MSU-mediated immune responses in gout, which helps to better understand the mechanism of gout development.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28630380     DOI: IJIv14i2A1

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  8 in total

1.  Investigation of the Effects and Mechanisms of Dendrobium loddigesii Rolfe Extract on the Treatment of Gout.

Authors:  Kai-Hui Zhang; Mei-Qi Wang; Lu-Ling Wei; Cheng-Jing Feng; Yu-Si Zhang; Jian-Bei Teng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-30       Impact factor: 2.629

Review 2.  Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications.

Authors:  Jianan Zhao; Kai Wei; Ping Jiang; Cen Chang; Lingxia Xu; Linshuai Xu; Yiming Shi; Shicheng Guo; Yu Xue; Dongyi He
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

3.  PD-1 mRNA expression in peripheral blood mononuclear cells as a biomarker for different stages of primary gouty arthritis.

Authors:  Jing Su; Xuefang Zhang; Qing Zhao; Zhaodi Guo; Jianxiong Wu; Guoqiang Chen; Qianxin Liang; Zhixiang Chen; Zhiliang He; Xiuping Cai; Manlin Xie; Lei Zheng; Kewei Zhao
Journal:  J Cell Mol Med       Date:  2020-07-08       Impact factor: 5.310

4.  Gout Storm.

Authors:  Danilo Martins; Carolina Rodrigues Tonon; Rafael Lopes Pacca; Natanye Lemes Matchil; Luiz Antonio Jorge Junior; Dênis Silva Queiroz; Filipe Welson Leal Pereira; Alana Maia Silva; Vinicius Padovese; Marcelo Padovani de Toledo Moraes; Daniel Luiz da Silva; Vinicius Cardoso Nóbrega; Emilio Carlos Curcelli; Marina Politi Okoshi
Journal:  Am J Case Rep       Date:  2021-09-20

Review 5.  Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout.

Authors:  Zhilei Wang; Yuchen Li; Wenhao Liao; Ju Huang; Yanping Liu; Zhiyong Li; Jianyuan Tang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-10       Impact factor: 6.073

6.  Hypomethylation of the opioid receptor delta 1 gene combined with high opioid receptor delta 1 protein levels indicates increased risk of gout.

Authors:  Ying Ying; Xiaoke Li; Yong Chen
Journal:  J Clin Lab Anal       Date:  2022-07-31       Impact factor: 3.124

7.  Metagenomic Analysis of Gut Microbiome in Gout Patients with Different Chinese Traditional Medicine Treatments.

Authors:  Jingjing Xie; Jing Wang; Fang Zhao; Xia Qiu; Jianwei Chen; Yangyang Jia; Panpan Qin; Yuanfang Zhu; Jianyong Zhang; Binbin Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-10       Impact factor: 2.650

8.  Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout.

Authors:  Limei Zhong; Sitao Li; Yi Wen; Junhui Zheng; Fengbin Liu; Donglin Cao; Yufeng Liu
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.